openPR Logo
Press release

Tacrolimus Market - Latest Innovations, Drivers and Industry Key Events 2018-2026 | GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Mylan N.V., Astellas Pharma, Inc.

10-14-2020 01:32 PM CET | Health & Medicine

Press release from: COHERENT MARKE INSIGHTS

Tacrolimus Market

Tacrolimus Market

Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection. Tacrolimus inhibits the activation of serine-threonine phosphatase, calcineurin, in T lymphocytes. This suppresses T lymphocyte activation and the subsequent generation of cytotoxic lymphocytes, thereby suppressing processes leading to organ rejection. Tacrolimus is primary immunosuppression drug used in kidney and liver transplant patients. Organ transplanted patients often require lifelong treatment with immunosuppressant. Major applications of this includes in cardiac transplant rejection, liver transplant rejection, kidney transplant rejection, and lung transplant immunosuppression treatment. Tacrolimus is available in various dosage forms such as tablets, capsules, and injections.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2298

Tacrolimus Market Drivers

Tacrolimus is majorly used as an immunosuppressant after organ transplant procedures. Advancement in organ transplant procedures is a major factor expected to increase the number of organ transplants, which in turn is expected to boost global tacrolimus market growth over the forecast period. For instance, new methods are being researched to match more donor organs with patients such as stem cell studies, trophic factor studies, and natural models. As the need for organ transplantation increases and the waiting list continues to grow, successful utilization and transplantation of as many available donor organs as possible has become important. According to Organ Procurement and Transplantation Network (OPTN) 117,000+ number of men, women, and children are on the national transplant waiting list as of July 2017 in the U.S. and 17,155 organ transplants are done so far in 2017.

Moreover, according to National Kidney Foundation as of 2016, 121,678 people are waiting for lifesaving organ transplants in the U.S., of which 100,791 people are waiting for kidney transplants. Moreover, organ transplantation procedures have evolved with increase in feasibility and better understanding of immunology, which has allowed for improved matching rates for organs and patients after transplants. This is expected to result in increasing number of organ transplants which is expected to support the global tacrolimus market growth over the forecast period.

Certain side effects (malignancy, Psychosis, and others) of tacrolimus, although not significant, may hamper the global tacrolimus market growth. However, major growth limiting factor is expected to be significant gap between demand and supply of transplant organs, which indirectly could affect the global tacrolimus market growth.

Tacrolimus Market Regional Analysis

North America tacrolimus market is expected to dominate over the forecast period. Presence of leading manufacturers as well as high number of organ transplant procedures is expected to support global tacrolimus market growth. Regional generic manufacturers are focusing on providing generic version of tacrolimus formulations in developed as well emerging economies. For instance, Strides Arcolab received the U.S. Food & Drug Administration (FDA) approval for tacrolimus capsules to be used as immuno-suppressant in 2014. Sandoz launched Tacrolimus, a generic version of Astellas’s PROGRAF (tacrolimus) in Japan, in 2015. Moreover, The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization for tacrolimus’ generic, Tacforius in 2017. These factors have supported the global tacrolimus market growth.

Tacrolimus Market Key Players

Key players operating in the global tacrolimus market include GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Mylan N.V., Astellas Pharma, Inc., Takeda Pharmaceuticals Company Ltd, Senju Pharmaceutical Co. Ltd., Guike Pharmaceutical Co. Ltd., DR. Reddy’s Laboratories Ltd., and Glenmark Pharmaceuticals Ltd.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/tacrolimus-market-2298

Tacrolimus Market Taxonomy:

The global tacrolimus market is segmented on the basis of product type, application, end user, and region

By Product Type:

Tacrolimus Capsules and Tablets
Tacrolimus Ointment
Tacrolimus Injection
By Application:

Immunosuppression
Dermatitis
Others
By End User:

Organ Transplant Centers
Hospitals
Clinics
By Region:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tacrolimus Market - Latest Innovations, Drivers and Industry Key Events 2018-2026 | GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Mylan N.V., Astellas Pharma, Inc. here

News-ID: 2159214 • Views: 523

More Releases from COHERENT MARKE INSIGHTS

Anti-Epileptic Drugs for Pediatrics Market Key Factors And Emerging Opportunitie …
Anti-epileptic drugs for pediatric treatment are expected to experience visible shifts in terms of demand and adoption owing to factors such as rise in global prevalence of epilepsy, increasing healthcare spending and emergence of efficacious anti-epileptic drugs. Furthermore, co-morbidities associated with epilepsy such as depression and anxiety are on the rise and major players are investing in research and awareness programs for reduction of these co-morbidities along with epilepsy. For instance,
Guidewires Market Industrial Output, Import & Export, Consumer Consumption and F …
Guidewires are flexible and thin tubes that guide a catheter for placement in the diseased organ. Guidewires are used to open the target vessels, cross lesions and provide definitive interventional therapy to patients. Guidewires are the crucial components of vascular intervention with indispensable uses in the field of minimally invasive surgeries due to its capacity of rendering precise and effective results. Guidewires are of several types as various clinical presentations
Big Data in Healthcare Market Growth Probability, Key Vendors and Future Scenari …
Big data in healthcare market revenue is expected to grow at lucrative rate over the forecast period primarily due to increased digitalization in industrial process. Digitization is transforming industrial processes, functions, products, and services. Advent of e-commerce has resulted in a sudden spurt in data being generated by various companies. Also, with decades of research and development activities across the healthcare industry, there is a large amount of data, referred
Cannabis Testing Service Market Application 2020- Industry Overview, Global Tren …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Global Cannabis Testing Service Market - Competitive Landscape Key players operating in

All 5 Releases


More Releases for Tacrolimus

Tacrolimus Injection Market 2019 | Analyzing The Impact Followed By Restraints, …
" DataIntelo offers a detailed report on Global Tacrolimus Injection Market. The report is a comprehensive research study that provides the scope of Tacrolimus Injection market size, industry growth opportunities and challenges, current market trends, potential players, and expected performance of the market in regions for the forecast period from 2020 to 2027. This report highlights key insights on the market focusing on the possible requirements of the clients and assisting
Tacrolimus Market to Exhibit Impressive Growth During 2018-2026 Including Global …
Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection. Tacrolimus inhibits the activation of serine-threonine phosphatase, calcineurin, in T lymphocytes. This suppresses T lymphocyte activation and the subsequent generation of cytotoxic lymphocytes, thereby suppressing processes leading to organ rejection. Tacrolimus is primary immunosuppression drug used in kidney and liver transplant patients. Organ transplanted patients often require lifelong treatment with immunosuppressant. Major applications of this
Global Tacrolimus Market Analysis of Demand, Supply, Growth, Forecast till 2024 …
Global Tacrolimus Market Research Report 2019 to 2024 segmented by product type, applications and offers complete Tacrolimus details including recent trends, Tacrolimus statistics, and growth factors. An in-depth study of leading Tacrolimus market players, supply chain scenario, business strategies and Tacrolimus development scenario is presented in this report. Various factors like Tacrolimus growth scenario, value chain analysis, deployment status and Tacrolimus industry landscape scenario are presented in this report. The
Global Tacrolimus Market Research by Top Players:-Roche Pharma, Abbott, Sandoz, …
This research report titled “Global Tacrolimus Market Insights, Forecast to 2025” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Tacrolimus Market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to enlighten the
Global Tacrolimus Market Overview by Business Manufactures with Forecast Analysi …
In this report, the global Tacrolimus market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Tacrolimus for these regions, from 2013 to 2025 (forecast), covering
Excellent Growth of Tacrolimus Market | Global Forecasts 2018 - 2025
This report studies the global Tacrolimus market status and forecast, categorizes the global Tacrolimus market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Tacrolimus market is valued at million US$ in 2017 and will reach million US$ by